ATOPIC DERMATITIS

Sep
2017
Vol. 36. No. 3

Introduction

While various medical specialties treat eczema patients, care for these patients is largely fragmented and disorganized. Moreover, standardized treatment protocols that incorporate upcoming eczema therapies and emerging guidelines have yet to be established. Thus, there is both a need and an opportunity to equip clinicians to succeed in this novel and changing era of eczema care. The National Eczema Association’s (NEA) strategic plan—developed through extensive discussions with patients who have atopic dermatitis and their caregivers, industry, and providers representing different specialties—called for the creation of an interdisciplinary coalition to steer this initiative. The Coalition United for Better Eczema Care (CUBE-C) is a network of cross-specialty leaders working to help construct an educational curriculum based on standards of effective treatment and disease management.

Curriculum United for Better Eczema Care: why, how, and what?

Andrea Waldman, MD | David Fleischer, MD | Dawn Marie Davis, MD | Jonathan Spergel, PhD | Jusleen Ahluwalia, MD | Lawrence F. Eichenfield, MD
While various medical specialties treat eczema patients, care for these patients is largely fragmented and disorganized.
MORE

Diagnosis, comorbidity, and psychosocial impact of atopic dermatitis

Andrea Waldman, MD | Dawn Marie Davis, MD | Jennifer LeBovidge, PhD | Jonathan Spergel, PhD | Jusleen Ahluwalia, MD | Megha M Tollefson, MD | Nathan Jetter, BS | Sharon E Jacob, MD
Understanding both the clinical characteristics and implications of AD is critical to lessening the psychosocial, clinical, and economic burden of this disease.
MORE

Atopic dermatitis: pathogenesis

Andrea Waldman, MD | Emma Guttman-Yassky, MD | Jusleen Ahluwalia, MD | Lawrence F. Eichenfield, MD | Peck Y Ong, MD
This article details the pathogenesis section of the Curriculum United for Better Eczema Care (CUBE-C), facilitating primary care and sub-specialist education on the scientific advances driving recent AD therapeutic innovations.
MORE

Atopic dermatitis: addressing allergy, infection, itch and complementary therapies

Adam Friedman, MD | Andrea Waldman, MD | Dawn Marie Davis, MD | Jeffrey Bienstock, MD | Jennifer LeBovidge, PhD | Jonathan Spergel, PhD | Jusleen Ahluwalia, MD | Luz Fonacier, MD | Nathan Jetter, BS | Peter Lio, MD | Peter Y Ong, MD | Sharon E Jacob, MD | Stuart Cohen, MD
This review summarizes allergy, infections, itch in AD, and discusses various alternative and complementary therapies.
MORE